PCSK9 drugs

verdict damages punitive damages compensatory damages lawsuit
Pharma

Amgen owes Regeneron $407M after defeat in PCSK9 antitrust suit

In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has eked out another legal win.
Fraiser Kansteiner May 15, 2025 3:52pm
boxing gloves

Amgen hits back at Sanofi, Regeneron in long-running patent feud

Mar 9, 2023 9:38am